aPTT of 37 Seconds in a Patient on Warfarin 2.5 mg: Interpretation
An aPTT of 37 seconds in a patient taking warfarin 2.5 mg daily is likely normal or minimally elevated and reflects the expected effect of warfarin on this test, not a cause for concern regarding over-anticoagulation. The critical test to monitor warfarin therapy is the INR, not the aPTT.
Why aPTT is Not the Right Test for Warfarin Monitoring
Warfarin should be monitored exclusively with PT/INR, not aPTT 1. The PT/INR reflects the depression of vitamin K-dependent factors (VII, X, and II) that warfarin affects, providing the standardized measure needed to assess anticoagulation intensity 1.
Warfarin's Effect on aPTT
- Warfarin does elevate aPTT, even without heparin present 2
- This elevation is expected and does not indicate a problem
- The FDA label explicitly states: "Warfarin sodium tablets may increase the activated partial thromboplastin time (aPTT) test, even in the absence of heparin" 2
Research confirms this effect:
- For each 1.0 increase in INR, aPTT increases by approximately 16 seconds 3
- Patients on therapeutic warfarin (PT 1.5-2.5 times control) show statistically significant aPTT elevation compared to baseline 4
- Good linear correlation exists between PT elevation and aPTT elevation (r = 0.821) 4
What You Should Do
Check the PT/INR immediately - this is the only appropriate test for assessing warfarin effect 1.
Therapeutic INR Targets
- Most indications: INR 2.0-3.0
- High-risk conditions (some mechanical heart valves): INR 2.5-3.5
- INR >4.0 provides no additional benefit and increases bleeding risk 2
Monitoring Schedule
- Daily PT/INR until results stabilize in therapeutic range 2
- Once stable: every 1-4 weeks depending on patient reliability 1, 2
- Additional testing when medications are changed or taken irregularly 2
Important Caveats
When aPTT Matters with Warfarin
The only clinically significant scenario where aPTT elevation matters in warfarin patients is:
Severe aPTT elevation (>50 seconds) with therapeutic INR indicates increased postoperative hemorrhage risk 2, 5:
- In postoperative patients, aPTT >50 seconds (even with appropriate PT control) was associated with 26.3% major bleeding complications versus 4.5% in those with aPTT <50 seconds 5
- Your patient's aPTT of 37 seconds does not meet this threshold
If Patient is Also on Heparin
If concurrent heparin therapy is present:
- aPTT reflects combined effects of both drugs 2, 3
- For accurate INR measurement, draw blood at least:
- 5 hours after last IV heparin bolus
- 4 hours after stopping continuous IV heparin
- 24 hours after subcutaneous heparin 2
Bottom Line
Ignore the aPTT value of 37 seconds and obtain a PT/INR to properly assess this patient's anticoagulation status. The aPTT is not a monitoring tool for warfarin therapy and its mild elevation is an expected pharmacologic effect of the drug. Only the INR can tell you whether the patient is under-anticoagulated, therapeutic, or over-anticoagulated.